{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:47Z","timestamp":1790315087727,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0847-2","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T11:05:45Z","timestamp":1533207945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries"],"prefix":"10.1186","volume":"18","author":[{"given":"Wenhui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-6059","authenticated-orcid":false,"given":"Hongxia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"EASL clinical practice guidelines","year":"2012","unstructured":"EASL clinical practice guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167\u201385.","journal-title":"J Hepatol"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.2.36","volume":"2","author":"CQ Pan","year":"2005","unstructured":"Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci. 2005;2:36\u201340.","journal-title":"Int J Med Sci"},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. New Engl J Med. 1975;292:771\u20134.","journal-title":"New Engl J Med"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hep.1840030201","volume":"3","author":"RP Beasley","year":"1983","unstructured":"Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (Baltimore, Md). 1983;3:135\u201341.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/ecco-jcc\/jjw087","volume":"10","author":"LJ Smits","year":"2016","unstructured":"Smits LJ, Derikx LA, de Jong DJ, Boshuizen RS, van Esch AA, Drenth JP, et al. Clinical outcomes following a switch from Remicade(R) to the biosimilar CT-P13 in inflammatory bowel disease patients: a prospective observational cohort study. J Crohns Colitis. 2016;10:1287\u201393.","journal-title":"J Crohns Colitis"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","volume":"55","author":"GR Han","year":"2011","unstructured":"Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55:1215\u201321.","journal-title":"J Hepatol"},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1158\/1078-0432.CCR-05-1095","volume":"11","author":"MH Chang","year":"2005","unstructured":"Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang DC, et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res. 2005;11:7953\u20137.","journal-title":"Clin Cancer Res"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/jnci\/djp288","volume":"101","author":"MH Chang","year":"2009","unstructured":"Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer I. 2009;101:1348\u201355.","journal-title":"J Natl Cancer I"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142:773\u201381. e2","journal-title":"Gastroenterology"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00431-006-0327-5","volume":"166","author":"YM Song","year":"2007","unstructured":"Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007;166:813\u20138.","journal-title":"Eur J Pediatr"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","volume":"170","author":"RD Burk","year":"1994","unstructured":"Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis. 1994;170:1418\u201323.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"847_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1478-3231.2008.01933.x","volume":"29","author":"MM Jonas","year":"2009","unstructured":"Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29(Suppl 1):133\u20139.","journal-title":"Liver Int"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","volume":"16","author":"WM Xu","year":"2009","unstructured":"Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepatitis. 2009;16:94\u2013103.","journal-title":"J Viral Hepatitis"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1365-2893.2003.00440.x","volume":"10","author":"M van Zonneveld","year":"2003","unstructured":"van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepatitis. 2003;10:294\u20137.","journal-title":"J Viral Hepatitis"},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/hep.510270634","volume":"27","author":"K Chayama","year":"1998","unstructured":"Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology (Baltimore, Md). 1998;27:1711\u20136.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","volume":"10","author":"CQ Pan","year":"2012","unstructured":"Pan CQ, Han GR, Jiang HX, Zhao W, Cao MK, Wang CM, et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol H. 2012;10:520\u20136.","journal-title":"Clin Gastroenterol H"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10620-014-3486-7","volume":"60","author":"M Buti","year":"2015","unstructured":"Buti M, Tsai N, Petersen J, Flisiak R, Gurel S, Krastev Z, et al. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection. Digestive Dis Sci. 2015;60:1457\u201364.","journal-title":"Digestive Dis Sci"},{"key":"847_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology (Baltimore, Md). 2014;60:468\u201376.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s10620-012-2187-3","volume":"57","author":"CQ Pan","year":"2012","unstructured":"Pan CQ, Mi LJ, Bunchorntavakul C, Karsdon J, Huang WM, Singhvi G, et al. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Digestive Dis Sci. 2012;57:2423\u20139.","journal-title":"Digestive Dis Sci"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","volume":"61","author":"AJ Greenup","year":"2014","unstructured":"Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol. 2014;61:502\u20137.","journal-title":"J Hepatol"},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed). 2009;339:b2535.","journal-title":"BMJ (Clinical research ed)"},{"key":"847_CR22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","volume":"85","author":"J Sim","year":"2005","unstructured":"Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257\u201368.","journal-title":"Phys Ther"},{"key":"847_CR23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928.","journal-title":"BMJ (Clinical research ed)."},{"key":"847_CR24","first-page":"3","volume-title":"3rd Symposium on Systematic Reviews: Beyond the Basics","author":"G Wells","year":"2000","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. In: 3rd Symposium on Systematic Reviews: Beyond the Basics; 2000. p. 3\u20135."},{"key":"847_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327:557\u201360.","journal-title":"BMJ (Clinical research ed)"},{"key":"847_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"847_CR27","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer I. 1959;22:719\u201348.","journal-title":"J Natl Cancer I"},{"key":"847_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"847_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997;315:629\u201334.","journal-title":"BMJ (Clinical research ed)"},{"key":"847_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MEG.0000000000000793","volume":"29","author":"PO Sellier","year":"2017","unstructured":"Sellier PO, Maylin S, Bercot B, Chopin D, Lopes A, Simoneau G, et al. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. Eur J Gastroenterol Hepatol. 2017;29:259\u201363.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"847_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3851\/IMP2981","volume":"20","author":"J Wang","year":"2015","unstructured":"Wang J, Liu J, Qi C, Yan T, Cao F, Jin L, et al. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV. Antiviral Ther. 2015;20:681\u20137.","journal-title":"Antiviral Ther"},{"key":"847_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40272-017-0229-1","volume":"19","author":"N Chamroonkul","year":"2017","unstructured":"Chamroonkul N, Piratvisuth T. Hepatitis B during pregnancy in endemic areas: screening, treatment, and prevention of mother-to-child transmission. Paediatric Drugs. 2017;19:173\u201381.","journal-title":"Paediatric Drugs"},{"key":"847_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132\u201343.","journal-title":"Gastroenterology"},{"key":"847_CR34","doi-asserted-by":"publisher","first-page":"e0140070","DOI":"10.1371\/journal.pone.0140070","volume":"10","author":"B Virine","year":"2015","unstructured":"Virine B, Osiowy C, Gao S, Wang T, Castillo E, Martin SR, et al. Hepatitis B virus (HBV) variants in untreated and Tenofovir treated chronic hepatitis B (CHB) patients during pregnancy and post-partum follow-up. PLoS One. 2015;10:e0140070.","journal-title":"PLoS One"},{"key":"847_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12879-016-1734-5","volume":"16","author":"G Jourdain","year":"2016","unstructured":"Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, et al. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. BMC Infect Dis. 2016;16:393.","journal-title":"BMC Infect Dis"},{"key":"847_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/hep.27837","volume":"62","author":"HL Chen","year":"2015","unstructured":"Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology (Baltimore, Md). 2015;62:375\u201386.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"847_CR37","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. New Engl J Medicine. 2016;374:2324\u201334.","journal-title":"New Engl J Medicine"},{"key":"847_CR38","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.3748\/wjg.v19.i48.9377","volume":"19","author":"MK Celen","year":"2013","unstructured":"Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol. 2013;19:9377\u201382.","journal-title":"World J Gastroenterol"},{"key":"847_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jvh.12436","volume":"23","author":"G Samadi Kochaksaraei","year":"2016","unstructured":"Samadi Kochaksaraei G, Castillo E, Osman M, Simmonds K, Scott AN, Oshiomogho JI, et al. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region. J Viral Hepatitis. 2016;23:15\u201322.","journal-title":"J Viral Hepatitis."},{"key":"847_CR40","first-page":"73","volume":"57","author":"WJ Chen","year":"2017","unstructured":"Chen WJ, Song SR, He H, Liang Q. Efficacy and safety of tenofovir, telbivudine in pregnancy to prevent perinatal transmission of hepatitis B virus. Shandong Med J. 2017;57:73\u20135.","journal-title":"Shandong Med J"},{"key":"847_CR41","first-page":"828","volume":"17","author":"JY Wan","year":"2017","unstructured":"Wan JY, Cai QE, Wang M. Efficacy and safety of tenofovir on blocking mother to child transmission of hepatitis B virus in virus high load pregenant women. China Tropical Med. 2017;17:828\u201330.","journal-title":"China Tropical Med"},{"key":"847_CR42","first-page":"176","volume":"19","author":"WY Qi","year":"2017","unstructured":"Qi WY, Zhao ZJ, Liu JQ. Clinical study on the effectiveness of tenofovir on blocking mother to child transmission of hepatitis B virus in pregnant women with chronic hepatitis B. Chinese J Med Guide. 2017;19:176\u20137.","journal-title":"Chinese J Med Guide"},{"key":"847_CR43","first-page":"24","volume":"55","author":"J Deng","year":"2017","unstructured":"Deng J, Chen Y, Jia G. Curative effect of tenofovir disoproxil in the treatment of hepatitis B pregnant women and its effect on blocking mother to child transmission of hepatitis B virus. China Modern Doctor. 2017;55:24\u20136.","journal-title":"China Modern Doctor"},{"key":"847_CR44","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/apt.12726","volume":"39","author":"V Nguyen","year":"2014","unstructured":"Nguyen V, Tan PK, Greenup AJ, Glass A, Davison S, Samarasinghe D, et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment Pharm Therap. 2014;39:1225\u201334.","journal-title":"Aliment Pharm Therap"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-018-0847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T05:40:12Z","timestamp":1604727612000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0847-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"121"}}